A comparison of beclomethasone, salmeterol, and placebo in children with asthma

New England Journal of Medicine

Volumn 337, Issue 23, 1997, Pages 1659-1665

  Simons, F Estelle R ^a  

^a CHILDREN S HOSPITAL RESEARCH INSTITUTE OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BECLODISK; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; PLACEBO; SALMETEROL XINAFOATE; UNCLASSIFIED DRUG;

ARTICLE; ASTHMA; BRONCHODILATATION; BRONCHUS HYPERREACTIVITY; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; SYMPTOMATOLOGY; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION;

EID: 0030725172     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199712043372304     Document Type: Article

References (35)

1. Murphy S, Sheffer AL, Pauwels RA. National Asthma Education and Prevention Program: highlights of the expert panel report II: guidelines for the diagnosis and management of asthma. Bethesda, Md.: National Heart, Lung, and Blood Institute, 1997. (NIH publication no. 97-4051.)
2. Warner JO, Naspitz CK, Cropp GJ. Third international pediatric consensus statement on the management of childhood asthma. Pediatr Pulmonol (in press).
3. van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, et al. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. Am Rev Respir Dis 1992;146:547-54.
4. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994;88:373-81.
5. Tinkelman DG, Reed CE, Nelson HS, Offord KP. Aerosol beclometh asone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics 1993;92: 64-77.
6. Verberne AAPH, Frost C, Bogaard JM, Kerrebijn KF, Dutch Pediatric Asthma Study Group. One year treatment with salmeterol compared to inhaled corticosteroid in children with mild to moderate asthma. Am J Respir Crit Care Med 1996;153:Suppl:A408. abstract.
7. Allen DB, Mullen M, Mullen B. A meta-analysis of the eftect of oral and inhaled corticosteroids on growth. J Allergy Clin Immunol 1994;93:967-76.
8. Simons FER, Soni NR, Watson WTA, Becker AB. Bronchodilator and bronchoprotective effects of salmeterol in young patients with asthma. J Allergy Clin Immunol 1992;90:840-6.
9. Verberne AAPH, Hop WCJ, Bos AB, Kerrebijn KF. Effect of a single dose of inhaled salmeterol on baseline airway caliber and methacholine-induced airway obstruction in asthmatic children. J Allergy Clin Immunol 1993;91:127-34.
10. Green CP, Price JF. Prevention of exercise induced asthma by inhaled salmeterol xinafoate. Arch Dis Child 1992;67:1014-7.
11. Simons FER, Gerstner TV, Cheang MS. Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment. Pediatrics 1997;99: 655-9.
12. Verberne AAPH, Hop WCJ, Creyghton FBM, et al. Airway responsiveness after a single dose of salmeterol and during four months of treatment in children with asthma. J Allergy Clin Immunol 1996;97:938-46.
13. Meijer GG, Postma DS, Mulder PGH, van Aalderen WMC. Long-term circadian effects of salmeterol in asthmatic children treated with inhaled corticosteroids. Am J Respir Crit Care Med 1995;152:1887-92.
14. Cockcroft DW, Killian DN, Mellon JJA, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977;7:235-43.
15. Gardner RM. Standardization of spirometry: a summary of recommendations from the American Thoracic Society: the 1987 update. Ann Intern Med 1988;108:217-20.
16. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983;127:725-34.
17. Draper NR, Smith H. Applied regression analysis. 2nd ed. New York: John Wiley, 1981.
18. Crowder MJ, Hand DJ. Analysis of repeated measures. London: Chapman & Hall, 1990.
19. Waalkens HJ, Van Essen-Zandvliet EE, Hughes MD, et al. Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration. Am Rev Respir Dis 1993;148: 1252-7.
20. van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Kerrebijn KF, Dutch CNSLD Study Group. Remission of childhood asthma after long-term treatment with an inhaled corticosteroid (budesonide): can it be achieved? Eur Respir J 1994;7:63-8.
21. Godfrey S, Konig P Treatment of childhood asthma for 13 months and longer with beclomethasone dipropionate aerosol. Arch Dis Child 1974;49:591-6.
22. Balfour-Lynn L. Growth and childhood asthma. Arch Dis Child 1986; 61:1049-55.
23. Volovitz B, Amir J, Malik H, Kauschansky A, Varsano I. Growth and pituitary-adrenal function in children with severe asthma treated with inhaled budesonide. N Engl J Med 1993;329:1703-8.
24. Merkus PJFM, van Essen-Zandvliet EEM, Duiverman EJ, van Houwelingen HC, Kerrebijn KF, Quanjer PH. Long-term effect of inhaled corticosteroids on growth rate in adolescents with asthma. Pediatrics 1993;91: 1121-6.
25. Silverstein MD, Yunginger JW, Reed CE, et al. Attained adult height after childhood asthma: effect of glucocorticoid therapy. J Allergy Clin Immunol 1997;99:466-74.
26. Wales JKH, Barnes ND, Swift PGF. Growth retardation in children on steroids for asthma. Lancet 1991;338:1535.
27. Thomas BC, Stanhope R, Grant DB. Impaired growth in children with asthma during treatment with conventional doses of inhaled corticosteroids. Acta Paediatr 1994;83:196-9.
28. Littlewood JM, Johnson AW, Edwards PA, Littlewood AE. Growth retardation in asthmatic children treated with inhaled beclomethasone dipropionate. Lancet 1988;1:115-6.
29. Saha M-T, Laippala P, Lenko HL. Growth of asthmatic children is slower during than before treatment with inhaled glucocorticoids. Acta Paediatr 1997;86:138-42.
30. Hunt GJJ, Edmunds ATE, Kelnar CJH. Height velocity standard deviation scores in 162 prepubertal children receiving beclomethasone dipropionate, budesonide, or sodium cromoglycate. Thorax 1994;49:399P. abstract.
31. Inoue T, Doi S, Takamatsu I, et al. Effects of inhaled beclomethasone on height growth and bone metabolism in children with asthma. Arerugi 1995;44:678-84.
32. Crowley S, Hindmarsh PC, Matthews DR, Brook CGD. Growth and the growth hormone axis in prepubertal children with asthma. J Pediatr 1995;126:297-303.
33. Doull IJM, Freezer NJ, Holgate ST. Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am I Respir Crit Care Med 1995;151:1715-9.
34. Donahue JG, Weiss ST, Livingston JM, Goetsch MA, Greineder DK, Platt R. Inhaled steroids and the risk of hospitalization for asthma. JAMA 1997;277:887-91.
35. White AJ, Richards DH. Inhaled corticosteroid prescribing in very young children. J Allergy Clin Immunol 1997;99:S325. abstract.